Aug 09, 2018
Perrigo Company plc Reports Second Quarter 2018 Financial Results
Aug 09, 2018
Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business
Aug 09, 2018
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
Aug 01, 2018
Perrigo Announces Quarterly Dividend
Jul 26, 2018
Perrigo To Release Second Quarter Calendar Year 2018 Financial Results On August 9, 2018
Jun 05, 2018
You Don't Need Sun to Feel the Burn This Summer
May 30, 2018
Perrigo to Present at the Jefferies 2018 Healthcare Conference
May 24, 2018
Perrigo Confirms Patent Challenge For Generic Version Of Sernivo® Spray, 0.05%
May 14, 2018
Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate® Lotion, 0.05%
May 11, 2018
Perrigo Expects Complete Response Letter On Generic Version Of ProAir®
May 08, 2018
Perrigo Company plc Reports First Quarter 2018 Financial Results
May 03, 2018
Perrigo Announces Quarterly Dividend
Apr 27, 2018
Amneal And Impax Receive FTC Clearance For Business Combination
Apr 24, 2018
Perrigo To Release First Quarter Calendar Year 2018 Financial Results On May 8, 2018
Apr 11, 2018
Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn
Apr 06, 2018
Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)
Mar 07, 2018
Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets
Mar 07, 2018
Perrigo to Present at Upcoming Investor Conferences
Mar 01, 2018
Perrigo Company plc Reports Fourth Quarter & Calendar Year 2017 Financial Results
Mar 01, 2018
Perrigo Files Form 10-K With SEC; Will Host Fourth Quarter And Calendar Year 2017 Financial Results Conference Call On March 2, 2018